Home

Drug Crisis: What is the Virginia State Doing to Control the Epidemic?

Pre-Conditions for the Growth of Addiction

The United States faces a severe opioid crisis that has evolved significantly over the past two decades. In 2023, fentanyl was responsible for approximately 199 deaths every day, with over a quarter of a million Americans dying from fentanyl overdoses since 2021. The crisis extends beyond opioids to include methamphetamine and other synthetic drugs, creating a multifaceted public health emergency. While prescription opioid misuse remains a concern, with up to 96% of opioid abusers misusing prescription opioids at least once annually, the landscape has shifted dramatically toward illicitly manufactured synthetic opioids.

The origins of this crisis trace back to the aggressive marketing of prescription opioids in the 1990s and 2000s, when pharmaceutical companies downplayed addiction risks and healthcare providers increasingly prescribed these medications for pain management. As regulatory measures tightened around prescription opioids, individuals with established dependencies turned to illicit alternatives, particularly heroin and synthetic opioids like fentanyl. The proliferation of fentanyl—an opioid 50 to 100 times more potent than morphine—into illegal drug supplies has exponentially increased overdose deaths. Additionally, the combination of opioids with other substances such as benzodiazepines, methamphetamine, and stimulants has created unpredictable and highly lethal drug mixtures. Social factors including economic despair, limited access to mental health and addiction treatment services, and community-level trauma have further accelerated the spread of addiction across all demographic groups.

Social and Economic Impacts

The opioid crisis exerts enormous pressure on healthcare systems throughout the United States. Emergency departments experience surging visits related to overdoses and complications from substance use disorders, diverting resources from other critical care needs. The healthcare costs associated with treatment, hospitalization, and management of overdose complications are staggering, while addiction medicine and mental health treatment services remain chronically underfunded and inaccessible in many regions. Neonatal opioid withdrawal syndrome has become a significant pediatric health crisis, affecting thousands of infants born to mothers with opioid use disorders. Additionally, the broader health consequences of addiction—including infectious diseases transmitted through injection drug use, cardiovascular complications, and psychiatric comorbidities—create cascading healthcare demands that strain provider capacity and increase overall system costs.

Beyond healthcare, the opioid crisis devastates public safety infrastructure, the criminal justice system, and economic productivity. Law enforcement agencies dedicate substantial resources to drug-related arrests and investigations, while incarceration for drug offenses perpetuates cycles of poverty and addiction in affected communities. The crisis reduces workforce participation and productivity as individuals struggle with addiction, and employers face increased healthcare costs and workplace disruptions. Families experience financial instability when breadwinners become disabled or incarcerated due to substance use disorders. Child welfare systems are overwhelmed managing cases involving parental substance abuse, requiring costly foster care and social services interventions. Communities experience elevated crime rates, property devaluation, and social fragmentation, with entire neighborhoods and towns experiencing population decline and economic deterioration as the crisis deepens.

Federal Countermeasures

The federal government has implemented numerous initiatives to combat the opioid crisis, though identifying the five most recent and effective actions requires careful examination of current data. However, the search results provided focus primarily on data presentation and state-level responses rather than comprehensive federal initiative information. Based on available information, the federal response includes coordination through agencies such as the CDC, which maintains the National Vital Statistics System to track overdose deaths and inform policy decisions. The federal government has also supported data infrastructure development and analysis at the state level, enabling evidence-based policymaking. While additional federal initiatives certainly exist—such as funding for medication-assisted treatment, naloxone distribution programs, and research into fentanyl countermeasures—the specific details of the five most recent and impactful federal actions are not fully detailed in the available search results.

Virginia Case - The Numbers Speak for Themselves

Virginia faces a significant opioid crisis, though the state has demonstrated encouraging progress in recent years as detailed at https://www.wfmh.org/stats/virginia-drug-alcohol-statistics. According to available data, 2,078 people died from opioid overdose in Virginia in 2023, representing a rate of 24.1 deaths per 100,000 people. However, Virginia achieved a notable 43% reduction in the rate of opioid overdose deaths in 2024, indicating that state interventions are showing measurable success. The crisis has generated substantial economic costs—in 2023 alone, the opioid epidemic cost Virginia $5.2 billion across healthcare, lost labor productivity, child services, K-12 education, and criminal justice sectors. Synthetic opioids, particularly fentanyl, are involved in the overwhelming majority of overdose deaths in Virginia, reflecting the national trend toward illicitly manufactured drugs rather than pharmaceutical opioids.

Virginia's response to the crisis is grounded in data-driven decision-making through the Framework for Addiction Analysis and Community Transformation (FAACT). This initiative aggregates data from Virginia State Police, Emergency Medical Services, the Office of the Chief Medical Examiner, and the Department of Forensic Science to provide comprehensive insights into addiction patterns across the Commonwealth. FAACT enables Virginia decision-makers to identify populations at risk for substance use disorders and allocate limited treatment and recovery resources more effectively. This data infrastructure supports evidence-based policy development and targeted interventions in high-need communities and counties.

Virginia has also invested in the Virginia Opioid Cost Data Tool, launched in November 2025 by the VCU Center on Society and Health in collaboration with Altarum. This resource breaks down the distribution of costs incurred by the opioid crisis across different sectors and geographic locations, providing county-by-county insights that enable targeted resource allocation and highlight the specific impacts on local healthcare systems, criminal justice infrastructure, educational systems, and labor productivity. By making this cost data publicly available and transparent, Virginia empowers local stakeholders and policymakers to understand the specific burden of addiction in their communities and prioritize interventions accordingly.

Approaches in Neighboring Regions

West Virginia

• Strategy: Comprehensive Opioid Response and Data Tracking
  • West Virginia maintains detailed epidemiological data on drug overdose deaths, tracking the involvement of specific substances including fentanyl, heroin, methamphetamine, and prescription opioids over multi-year periods.
  • The state documents that fentanyl and fentanyl analogues were involved in 76% of all drug overdose deaths in 2021, up from 58% in 2017, demonstrating how synthetic opioids have come to dominate the overdose landscape.
  • West Virginia tracks the declining role of heroin (from 26.3% of deaths in 2017 to 3% in 2021) and the rising prevalence of methamphetamine-related deaths (from 22.8% to 52.2%), revealing how addiction patterns shift as drug supplies change.
  • This data-driven approach enables targeted interventions and resource allocation toward the specific substance use patterns affecting the state's population, informing treatment capacity development and law enforcement priorities.

North Carolina

• Strategy: Integrated Overdose Response and Synthetic Opioid Focus
  • North Carolina experienced 2,915 opioid overdose deaths in 2023, with opioids implicated as a factor in 82.8% of all overdose deaths statewide.
  • The state has prioritized understanding the role of synthetic opioids, particularly fentanyl, which are involved in 94.2% of opioid overdose deaths—indicating that nearly all opioid fatalities involve illicitly manufactured fentanyl rather than pharmaceutical medications.
  • North Carolina's approach recognizes that heroin plays a minimal role in the current overdose crisis, accounting for only 1.8% of opioid overdose deaths, allowing the state to redirect treatment and harm reduction resources toward addressing fentanyl contamination and synthetic opioid use disorders.
  • By tracking these specific substance involvement patterns, North Carolina can develop targeted naloxone distribution programs, fentanyl-specific education campaigns, and treatment modalities suited to synthetic opioid addiction rather than applying generic opioid interventions.

Maryland

• Strategy: Multi-Sector Response and Public Health Integration
  • Maryland, as a Mid-Atlantic state adjacent to Virginia and North Carolina, faces similar opioid crisis pressures driven by fentanyl and synthetic opioid proliferation.
  • The state has integrated opioid crisis response across healthcare, public health, law enforcement, and social services sectors, recognizing that effective intervention requires coordination beyond any single agency.
  • Maryland has invested in harm reduction strategies, treatment accessibility, and community-based recovery programs designed to address both acute overdose prevention and long-term addiction recovery needs.
  • By pooling resources and expertise across multiple state agencies and community organizations, Maryland has worked to ensure that individuals with opioid use disorders can access medication-assisted treatment, mental health services, and recovery support programs in their local communities.

Is It Possible to Stop the Crisis? Looking to the Future

Approaches with Demonstrated Potential for Effectiveness

• Investment in Evidence-Based Treatment and Medication-Assisted Treatment (MAT): Medication-assisted treatment combining medications such as methadone, buprenorphine, or naltrexone with behavioral therapy has strong empirical support for reducing illicit opioid use, overdose deaths, and relapse rates. Expanding access to MAT requires investment in treatment infrastructure, workforce development, and insurance coverage policies that remove financial and logistical barriers to participation. When individuals can access MAT quickly and maintain continuous care, overdose mortality and addiction-related incarceration decline significantly.
• Early Intervention and Screening in Healthcare Settings: Implementing universal screening for substance use disorder risk in primary care, emergency departments, and specialty healthcare settings enables early identification of individuals who could benefit from prevention or treatment interventions. Brief interventions combined with screening—such as motivational interviewing and referral to treatment—can prevent progression from experimental use to addiction. Schools and youth-serving organizations can implement evidence-based prevention programs that address risk factors and build protective factors before substance use begins.
• Interagency Cooperation and Data Sharing: As demonstrated by Virginia's FAACT initiative, comprehensive data systems that integrate information from healthcare, emergency services, law enforcement, and vital statistics enable stakeholders to identify high-risk populations, evaluate intervention effectiveness, and allocate resources efficiently. When police, healthcare providers, treatment organizations, and social services agencies share information and coordinate response, interventions become more targeted and comprehensive, addressing individuals' complex needs across multiple service systems.
• Community-Based Harm Reduction and Overdose Prevention: Naloxone distribution programs, supervised consumption sites, sterile syringe services, and fentanyl testing services reduce overdose deaths and infectious disease transmission while maintaining engagement with people who are not yet ready for treatment. These programs build trust with vulnerable populations and create touchpoints for connecting individuals to treatment and social services. Evidence consistently demonstrates that harm reduction approaches reduce death, disease, and crime while serving as gateways to recovery.
• Long-Term Supported Recovery and Aftercare Services: Simply achieving abstinence or stabilization on medication-assisted treatment is insufficient without sustained support. Peer recovery coaching, supported housing, employment services, family reunification support, and mental health treatment address the underlying conditions that increase relapse risk. Recovery support services that extend months or years beyond initial treatment create stability and allow individuals to rebuild lives, relationships, and community connections essential for sustained recovery.

Approaches with Limited Effectiveness or Demonstrated Drawbacks

• Incarceration as a Primary Response to Addiction: Criminalizing substance use and relying on incarceration as the primary response to addiction has failed to reduce drug use rates while creating enormous human and financial costs. Incarceration separates individuals from family and employment, disrupts medication-assisted treatment, and does not address underlying addiction biology or social determinants of drug use. Mass incarceration has not reduced opioid or other drug availability, and individuals released from incarceration face high overdose mortality risk due to loss of tolerance during confinement and reentry stress.
• Supply Reduction Alone Without Demand Reduction: Attempting to stop the opioid crisis through law enforcement and drug supply interdiction without simultaneously addressing addiction treatment demand has proven ineffective at the population level. As one illicit drug supply is disrupted, alternative drugs or suppliers emerge quickly, as demonstrated by the shift from heroin to fentanyl and fentanyl analogues. Without reducing demand for opioids through treatment, the opioid epidemic persists despite significant law enforcement investment.
• Stigma-Based and Punitive Approaches: Approaches that stigmatize addiction or treat people with substance use disorders primarily as criminals rather than individuals with health conditions reduce treatment engagement and worsen outcomes. Pregnant individuals may avoid prenatal care due to fear of criminal prosecution; people with addiction may avoid emergency departments despite overdose risk; and communities affected by addiction may resist resource investment due to stigma. Compassionate, health-centered approaches that reduce stigma and treat addiction as a medical condition produce better outcomes.
• Brief Interventions Without Sustained Support: One-time educational campaigns, single emergency department visits, or brief counseling encounters without follow-up and sustained engagement produce minimal long-term behavior change in individuals with established addiction. While awareness campaigns may reach the general population, individuals struggling with opioid addiction require ongoing, coordinated, multi-disciplinary treatment and support. Brief interventions work best as gateways to sustained treatment rather than stand-alone solutions.
• Treatment Without Addressing Underlying Social Determinants: Treating addiction without addressing poverty, housing instability, employment barriers, mental health conditions, and trauma frequently results in relapse. Individuals who complete treatment but return to environments of poverty, social isolation, and untreated mental health conditions face extremely high relapse and overdose mortality risk. Comprehensive approaches that address addiction within the context of housing, employment, education, and mental health produce superior long-term outcomes.

Conclusions and Recommendations

The opioid and drug crisis demands urgent public health action grounded in compassion, science, and accountability to the populations affected. Every state bears responsibility for reducing addiction-related suffering and death within its borders, yet each state's path forward must be tailored to its specific epidemiology, resources, and community needs. Virginia's approach—built on reliable data infrastructure, transparent cost accounting, and evidence-based interventions—demonstrates that progress is possible even when facing entrenched addiction epidemiology.

A successful strategy is always based on reliable data that accurately reflects who is dying, what substances are involved, and which populations are at greatest risk. Open dialogue among government agencies, healthcare providers, law enforcement, community organizations, addiction specialists, and people with lived experience of addiction ensures that interventions reflect reality rather than ideology or stigma. Long-term support for individuals struggling with addiction—encompassing treatment access, harm reduction, recovery support services, housing, employment assistance, and family reunification—creates conditions where sustained recovery becomes possible. When states commit to these principles and invest accordingly, addiction crises can be arrested and reversed, transforming public health trajectories and restoring hope to affected individuals and communities.